NCT03233152
- Conditions
- Astrocytoma, Disease Attributes, Glioblastoma, +11 more
- Locations
-
- Universitair Ziekenhuis Brussel Brussels, Belgium
Clinical trial condition
Neuroectodermal Tumors
Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.
5,994 public trials
1,209 recruiting studies
Neuroectodermal Tumors trial results
Active, Not Recruiting
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
NCT04196452
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
Not specified
Active, Not Recruiting
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04250922
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
- Locations
-
- Institut Cancerologie de L'Ouest (ICO) Angers, France
- Centre Eugène Marquis (CEM) Rennes, France
- Gustave Roussy University Hospital Rennes, France
- Institut universitaire du cancer Toulouse, France
NCT05768880
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +23 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
Active, Not Recruiting
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
NCT03618381
- Conditions
- Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +60 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
Active, Not Recruiting
Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma
NCT06784648
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +27 more
- Locations
-
- Charité - Universitatsmedizin Berlin Berlin, Germany
- University Hospital Essen Essen, Germany
- University Hospital Heidelberg Heidelberg, Germany
- University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg and Clinical Cooperation Unit Dermato-Oncology(G300) German Cancer Research Center(DKFZ) Mannheim, Germany
Active, Not Recruiting
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation
NCT06146920
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
NCT05142241
- Conditions
- Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, +8 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
NCT05973487
- Conditions
- Adnexal Diseases, Anogenital Cancers, Cervical Cancer, +47 more
- Locations
-
- HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
- University of California San Diego San Diego, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Memorial Healthcare System Hollywood, Florida, United States
Active, Not Recruiting
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
NCT05812027
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
- Locations
-
- HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
- University of California San Diego San Diego, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Memorial Healthcare System Hollywood, Florida, United States